These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 17179582

  • 1. Estimate the insulin absorption in diabetic patients on peritoneal dialysis.
    Pantsulaia T, Chokhonelidze I, Lomitashvili T.
    Georgian Med News; 2006 Nov; (140):28-30. PubMed ID: 17179582
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
    Quellhorst E.
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
    [Abstract] [Full Text] [Related]

  • 4. Administration of insulin by continuous ambulatory peritoneal dialysis.
    Chan E, Montgomery PA.
    Pharmacotherapy; 1993 Jan; 13(5):455-60. PubMed ID: 8247911
    [Abstract] [Full Text] [Related]

  • 5. Increased subcutaneous insulin requirements in diabetic patients recently commenced on peritoneal dialysis.
    Szeto CC, Chow KM, Leung CB, Kwan BC, Chung KY, Law MC, Li PK.
    Nephrol Dial Transplant; 2007 Jun; 22(6):1697-702. PubMed ID: 17259649
    [Abstract] [Full Text] [Related]

  • 6. Intraperitoneal versus subcutaneous insulin in patients on nighttime IPD.
    Bargman JM.
    Adv Perit Dial; 1994 Jun; 10():116-9. PubMed ID: 7999807
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
    Rodrigues AS, Martins M, Korevaar JC, Silva S, Oliveira JC, Cabrita A, Castro e Melo J, Krediet RT.
    Am J Nephrol; 2007 Jun; 27(1):84-91. PubMed ID: 17284895
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intraperitoneal insulin in continuous ambulatory peritoneal dialysis (CAPD): clinical aspects.
    Triolo G, Carta Q, Salomone M, Dani F, Passarino G, Boggio Bertinet D, Segoloni GP, Vercellone A.
    Life Support Syst; 1983 Jun; 1 Suppl 1():454-6. PubMed ID: 6400733
    [No Abstract] [Full Text] [Related]

  • 13. Peritoneal protein losses in diabetic patients starting peritoneal dialysis: is there a relationship with diabetic vascular lesions?
    Coronel F, Cigarrán S, Herrero JA, Delgado J, Ramos F, Gomis A.
    Adv Perit Dial; 2009 Jun; 25():115-8. PubMed ID: 19886331
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Absorption kinetics of insulin after subcutaneous administration.
    Søeborg T, Rasmussen CH, Mosekilde E, Colding-Jørgensen M.
    Eur J Pharm Sci; 2009 Jan 31; 36(1):78-90. PubMed ID: 19028573
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Intraperitoneal insulin in continuous ambulatory peritoneal dialysis].
    Riambau E, Aubia J, Llorach I, Lloveras J, Masramón J, Orfila A, Llorach M.
    Rev Clin Esp; 1982 Mar 15; 164(5):333-4. PubMed ID: 7048442
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.